Article
Recognition determinants of broadly neutralizing human antibodies against dengue viruses.
Nature - 2 Apr 2015
Rouvinski Alexander, Guardado-Calvo Pablo, Barba-Spaeth Giovanna, Duquerroy Stéphane, Vaney Marie-Christine, Kikuti Carlos M, Navarro Sanchez M Erika, Dejnirattisai Wanwisa, Wongwiwat Wiyada, Haouz Ahmed, Girard-Blanc Christine, Petres Stéphane, Shepard William E, Desprès Philippe, Arenzana-Seisdedos Fernando, Dussart Philippe, Mongkolsapaya Juthathip, Screaton Gavin R, Rey Félix A
Abstract excerpt
Dengue disease is caused by four different flavivirus serotypes, which infect 390 million people yearly with 25% symptomatic cases and for which no licensed vaccine is available. Recent phase III vaccine trials showed partial protection, and in particular no protection for dengue virus serotype 2 (refs 3, 4). Structural studies so far have characterized only epitopes recognized by serotype-specific human...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
